Marijuana Impairment
4
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by High Dose Thc Marijuana
Research Leaders
7 sponsors active, led by National Institute on Drug Abuse (NIDA)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (4)
Standardized Field Test for Marijuana Impairment II
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
Neuroscience of Marijuana Impaired Driving
Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
Research Network
Common Treatments
- High Dose Thc Marijuana2
- Low Dose Thc Marijuana2
- High Marijuana Hash Thc Or Grass1
- Dronabinol1
- Low Marijuana Hash Thc Or Grass1
Active Sponsors
- National Institute on Drug Abuse (NIDA)4
- Yale University4
- Hartford Hospital4
- National Highway Traffic Safety Administration (NHTSA)3
- The Mind Research Network2
Top Investigators
Founding Director, Olin Neuropsychiatry Center; Yale University
Founding Director Olin Research Center; Professor Yale University
Yale University
Related Conditions
- Alcohol Impairment1